Avacta Group Plc (LON:AVCT – Get Free Report)’s share price dropped 9.4% during trading on Monday . The company traded as low as GBX 71 ($0.91) and last traded at GBX 72.50 ($0.93). Approximately 1,581,982 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 2,618,438 shares. The stock had previously closed at GBX 80 ($1.02).
Avacta Group Trading Down 8.8 %
The stock has a market cap of £262.10 million, a P/E ratio of -888.89 and a beta of 1.22. The firm’s 50 day simple moving average is GBX 48.44 and its two-hundred day simple moving average is GBX 66.73. The company has a quick ratio of 4.96, a current ratio of 0.62 and a debt-to-equity ratio of 191.87.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Recommended Stories
- Five stocks we like better than Avacta Group
- 3 Tickers Leading a Meme Stock Revival
- Top 3 Defense Stocks That Should Be on Your Radar
- What Are Trending Stocks? Trending Stocks Explained
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
